Sanj K. Patel is CEO & Chairman at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have made 3 open-market trades across 1 company since 2012, most recently 2026-09-01.
CIK 0001532218
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2018, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KNSA | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $54.02 | $2.6M | +7.6% | -12.0% | +42.3% |
| KNSA | SELL · 10b5-1 | 2026-04-28 | 2026-04-30 | $51.96 | $26.4M | +11.4% | -9.3% | +51.6% |
| KNSA | SELL · 10b5-1 | 2026-04-06 | 2026-04-08 | $50.01 | $364K | -9.1% | +25.5% | +44.1% |
| KNSA | SELL · 10b5-1 | 2025-10-20 | 2025-10-22 | $38.86 | $20.0M | -3.6% | +7.0% | +5.6% |
| KNSA | SELL · 10b5-1 | 2025-05-23 | 2025-05-28 | $27.25 | $4.6M | +8.7% | +0.5% | +20.3% |
| KNSA | SELL · 10b5-1 | 2025-05-20 | 2025-05-22 | $27.02 | $127K | +11.4% | +10.8% | +28.1% |
| KNSA | SELL · 10b5-1 | 2025-05-13 | 2025-05-15 | $27.03 | $155K | +5.3% | +9.7% | +30.0% |
| KNSA | SELL · 10b5-1 | 2025-05-07 | 2025-05-09 | $27.04 | $382K | +0.5% | +16.7% | +27.3% |
| KNSA | SELL · 10b5-1 | 2024-11-06 | 2024-11-08 | $23.00 | $2.1M | -7.2% | -6.7% | -11.2% |
| KNSA | SELL · 10b5-1 | 2024-07-23 | 2024-07-25 | $25.79 | $5.7M | -6.5% | +6.1% | +3.4% |
| KNSA | SELL · 10b5-1 | 2024-03-07 | 2024-03-11 | $21.02 | $2.7M | -2.7% | -14.3% | -5.6% |
| KNSA | SELL · 10b5-1 | 2024-03-04 | 2024-03-06 | $21.33 | $591K | -6.8% | -14.8% | -8.0% |
| KNSA | SELL | 2021-02-08 | 2021-02-10 | $23.06 | $2.3M | -0.7% | +5.5% | -30.5% |
| KNSA | SELL | 2020-10-09 | 2020-10-14 | $21.02 | $7.4M | -5.8% | -19.0% | -2.4% |
| KNSA | SELL | 2020-03-06 | 2020-03-10 | $20.00 | $662K | -25.6% | -3.5% | +36.3% |
| GEVA | SELL · 10b5-1 | 2014-12-17 | 2014-12-19 | $88.85 | $4.4M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2014-01-28 | 2014-01-30 | $88.12 | $9.0M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2013-07-25 | 2013-07-29 | $48.02 | $4.8M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2013-06-11 | 2013-06-13 | $40.65 | $2.8M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2013-04-05 | 2013-04-09 | $49.68 | $1.6M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2013-04-03 | 2013-04-05 | $50.91 | $2.0M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2013-02-20 | 2013-02-22 | $49.19 | $3.4M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2012-12-13 | 2012-12-17 | $46.21 | $2.8M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2012-12-04 | 2012-12-06 | $48.91 | $1.7M | N/A | N/A | N/A |
| GEVA | SELL · 10b5-1 | 2012-11-30 | 2012-12-04 | $49.34 | $1.7M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.